Advertisement

Topics

Scancell Limited Company Profile

14:51 EDT 22nd June 2018 | BioPortfolio

Scancell Ltd is a company focused on the discovery and development of products that harness the immune system in a unique way to treat or prevent cancer. Founded in 1997 as a spin-out from the University of Nottingham, Scancell is based in state-of-the-art facilities at the BioCity innovation and technology centre, Nottingham. The Company, which currently employs 12 staff, has secured £4.7million of private equity and commercial funding to date. Scancell is focused in two areas: therapeutic monoclonal antibodies and cancer vaccines. Scancell’s first antibody, an EGFr antibody licensed to ISU Abxis, is expected to enter clinical trials within 12 months. Scancell has two further direct killing therapeutic antibodies against proprietary targets in preclinical development – both products are expected to be in clinical testing by the end of 2006. In addition, Scancell has two further vaccine products in development based on its proprietary ImmunoBody® vaccine technology.

Location

BioCity
Pennyfoot Street
Nottingham
Nottinghamshire
NG1 1GF
United Kingdom

Contact

Phone: 0115 912 4311
Fax: 0115 912 4317
Email: lindy.durrant@nottingham.ac.uk


News Articles [56 Associated News Articles listed on BioPortfolio]

Scancell and BioNTech Will Combine Their Expertise to Fight Cancer

Scancell has brought in BioNTech to develop T-cell receptors against specific target proteins in cancer cells, opening the door to new cancer treatments that target them.  Scancell works on immunothe...

Scancell poised for “significant” year with its immuno-oncology portfolio

"In our view, the potential for SCIB1 [Scancell's skin cancer treatment], as already demonstrated by the survival data, is remarkable," said one broker recently

Scancell buddies up with ‘new immuno-oncology powerhouse’

UK-based oncology specialist Scancell Holdings has announced a collaboration with Europe’s largest…

Scancell research collaboration deal with European biopharma BioNTech

Cancer immunotherapy specialist Scancell Holdings Plc (LON:SCLP) has entered into a research collaboration agreement with European biopharma BioNTech as the two look to develop innovative T-cell the...

Scancell to receive patent protection for key cancer platform

Once formally granted the patent will provide protection for Scancell’s pipeline of Moditope vaccines

BioNTech, Scancell collaborate on T-cell receptors for cancer

BioNTech AG and Scancell Ltd. are collaborating on the development of T-cell receptor-based therapeutics for cancer using each other's respective technologies.

Scancell inks research collaboration deal with European biopharma BioNTech

The research collaboration will combine Scancell’s Moditope immunotherapy platform and BioNTech’s platform technology for high-throughput cloning and characterisation of naturally selected T cell ...

New Scancell chief sets out his vision to commercialise groundbreaking cancer treatments

Cliff Holloway, chief executive of Scancell Holdings Plc (LON:SCLP), spoke to Proactive soon after taking over as CEO at the immuno-oncology company. Holloway says generating clinical data's a big...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [85 Associated Companies listed on BioPortfolio]

Scancell Holdings Plc

Scancell is developing novel therapeutic vaccines for the treatment of cancer and infectious diseases based on its groundbreaking ImmunoBody® technology platform. Scancellâ€...

Scancell Limited

Scancell Ltd is a company focused on the discovery and development of products that harness the immune system in a unique way to treat or prevent cancer. Founded in 1997 as a spin-out from the Univers...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Scancell Limited" on BioPortfolio

We have published hundreds of Scancell Limited news stories on BioPortfolio along with dozens of Scancell Limited Clinical Trials and PubMed Articles about Scancell Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Scancell Limited Companies in our database. You can also find out about relevant Scancell Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record